Pharma & Biotech
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
10.00 Mon 28 Sep 2020
Zynerba's CBD skin gel Zygel offers a goldmine of therapies for Fragile X syndrome, and other conditions
VolitionRx’s Nu.Q cancer-screening blood tests could replace colonoscopies, biopsies
Acasti Pharma eyeing FDA meeting as it continues to advance heart disease candidate CaPre
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.